Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment.

Portet, Sylvain; Naoufal, Rania; Tachon, Gaëlle; Simonneau, Adrien; Chalant, Anaïs; Naar, Amir; Milin, Serge; Bataille, Benoit; Karayan-Tapon, Lucie

Portet, Sylvain; Naoufal, Rania; Tachon, Gaëlle; Simonneau, Adrien; Chalant, Anaïs; Naar, Amir; Milin, Serge; Bataille, Benoit; Karayan-Tapon, Lucie.

Afiliación

Portet S; University of Poitiers, Poitiers, France.
Naoufal R; INSERM 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Tachon G; University Hospital of Poitiers, Poitiers, France.
Simonneau A; Department of Neurosurgery, University Hospital of Poitiers, Poitiers, France.
Chalant A; University Hospital of Poitiers, Poitiers, France.
Naar A; Cancer Biology Department, University Hospital of Poitiers, Poitiers, France.
Milin S; Department of Clinical Laboratory, Saint George Hospital University Medical Center, Beirut, Lebanon.
Bataille B; University of Poitiers, Poitiers, France.
Karayan-Tapon L; INSERM 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.

Neurooncol Adv ; 1(1): vdz003, 2019.

Article en En | MEDLINE | ID: mdl-32642646

Palabras clave

AKT1; PIK3CA; cyproterone acetate; meningioma; molecular pathology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google